Aspreva Pharmaceuticals to Present at the Sixth Annual Needham Biotechnology and Medical Technology Conference in New York



    VICTORIA, June 6 /CNW/ - Aspreva Pharmaceuticals Corporation (NASDAQ:  
ASPV; TSX: ASV) today announced that Noel Hall, President, will be presenting
at the Sixth Annual Needham Biotechnology and Medical Technology Conference in
New York.
    The 30 minute presentation will be followed by a 30 minute question and
answer session. Mr. Hall's presentation will take place on Wednesday, June
13th at 1:30 pm ET at the New York Palace Hotel.
    A live audio webcast of the presentation will be available to all
interested parties through a link posted on Aspreva's website at
www.aspreva.com in the Investors section.

    About Aspreva Pharmaceuticals

    Aspreva is a global pharmaceutical company focused on identifying,
developing, and, upon approval, commercializing evidence-based medicines for
patients living with less common diseases. Aspreva common stock is traded on
the NASDAQ Global Select Market under the trading symbol "ASPV" and on the
Toronto Stock Exchange under the trading symbol "ASV". Learn more at
www.aspreva.com.





For further information:

For further information: Sage Baker, VP, Investor Relations & Corporate
Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270,
sbaker@aspreva.com

Organization Profile

ASPREVA PHARMACEUTICALS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890